PCV53 Cost Comparison of Low Dose Dabigatran over Other NOVEL ORAL Anticoagulants for the Treatment of Patients with NON-Valvular Atrial Fibrillation WHO HAD NOT Previously Taken an ORAL Anticoagulant in Greece

Autor:	G Gourzoulidis, G. Papageorgiou, Georgia Kourlaba, K. Wammes, E. Delli
Rok vydání:	2020
Předmět:	medicine.medical_specialty Cost comparison business.industry Health Policy Low dose Public Health Environmental and Occupational Health Non valvular atrial fibrillation Dabigatran Internal medicine medicine Cardiology Oral anticoagulant business medicine.drug
Zdroj:	Value in Health. 23:S496
ISSN:	1098-3015
DOI:	10.1016/j.jval.2020.08.544
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4da1ec5c484004f8bf6ce5ccade73aca https://doi.org/10.1016/j.jval.2020.08.544 Zobrazit plný text záznamu Full Text from ScienceDirect